Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 1 |
Hassani et al. | no | yes: 2 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | yes | yes: 1 |
Pissara et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | yes | yes: 3 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0008537 | proteasome activator complex | 2 | 11 |
GO:0032991 | protein-containing complex | 1 | 11 |
Related structures:
AlphaFold database: E9AEQ0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.606 |
DOC_CYCLIN_yCln2_LP_2 | 44 | 50 | PF00134 | 0.686 |
DOC_MAPK_MEF2A_6 | 164 | 172 | PF00069 | 0.635 |
DOC_MAPK_MEF2A_6 | 93 | 102 | PF00069 | 0.568 |
DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.588 |
DOC_USP7_MATH_1 | 166 | 170 | PF00917 | 0.633 |
DOC_USP7_UBL2_3 | 151 | 155 | PF12436 | 0.565 |
LIG_14-3-3_CanoR_1 | 214 | 222 | PF00244 | 0.742 |
LIG_Actin_WH2_2 | 95 | 110 | PF00022 | 0.654 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.584 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.584 |
LIG_Clathr_ClatBox_1 | 182 | 186 | PF01394 | 0.514 |
LIG_FHA_1 | 53 | 59 | PF00498 | 0.672 |
LIG_FHA_2 | 14 | 20 | PF00498 | 0.571 |
LIG_PCNA_yPIPBox_3 | 103 | 116 | PF02747 | 0.599 |
LIG_SH2_STAP1 | 203 | 207 | PF00017 | 0.505 |
LIG_SH2_STAP1 | 48 | 52 | PF00017 | 0.665 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.498 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.571 |
LIG_SUMO_SIM_anti_2 | 14 | 20 | PF11976 | 0.605 |
LIG_UBA3_1 | 109 | 116 | PF00899 | 0.565 |
LIG_WRC_WIRS_1 | 196 | 201 | PF05994 | 0.589 |
MOD_CK2_1 | 13 | 19 | PF00069 | 0.563 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.450 |
MOD_CK2_1 | 60 | 66 | PF00069 | 0.668 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.671 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.695 |
MOD_GlcNHglycan | 186 | 190 | PF01048 | 0.547 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.608 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.514 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.461 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.628 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.520 |
MOD_N-GLC_1 | 215 | 220 | PF02516 | 0.787 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.736 |
MOD_NEK2_1 | 185 | 190 | PF00069 | 0.588 |
MOD_NEK2_2 | 77 | 82 | PF00069 | 0.654 |
MOD_PIKK_1 | 187 | 193 | PF00454 | 0.535 |
MOD_PKA_2 | 144 | 150 | PF00069 | 0.535 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.601 |
MOD_Plk_1 | 11 | 17 | PF00069 | 0.572 |
MOD_Plk_2-3 | 7 | 13 | PF00069 | 0.554 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.542 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.521 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.562 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.505 |
MOD_SUMO_for_1 | 183 | 186 | PF00179 | 0.486 |
MOD_SUMO_for_1 | 92 | 95 | PF00179 | 0.581 |
MOD_SUMO_rev_2 | 111 | 118 | PF00179 | 0.622 |
MOD_SUMO_rev_2 | 147 | 153 | PF00179 | 0.551 |
MOD_SUMO_rev_2 | 157 | 163 | PF00179 | 0.774 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3A8 | Leptomonas seymouri | 71% | 97% |
A0A0S4JD53 | Bodo saltans | 36% | 100% |
A0A1X0NKN6 | Trypanosomatidae | 45% | 90% |
A0A3Q8IHQ9 | Leishmania donovani | 97% | 100% |
A0A3R7MG26 | Trypanosoma rangeli | 49% | 96% |
A4HMA7 | Leishmania braziliensis | 85% | 100% |
A4IAX3 | Leishmania infantum | 97% | 100% |
D0A282 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 97% |
E9B5V5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 97% |